These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29507197)

  • 1. B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction.
    Chen L; Azuma T; Yu W; Zheng X; Luo L; Chen L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3126-3131. PubMed ID: 29507197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.
    Krempski J; Karyampudi L; Behrens MD; Erskine CL; Hartmann L; Dong H; Goode EL; Kalli KR; Knutson KL
    J Immunol; 2011 Jun; 186(12):6905-13. PubMed ID: 21551365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.
    Jiang W
    Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
    Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
    Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
    Ramarathinam L; Castle M; Wu Y; Liu Y
    J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
    Chen L; McGowan P; Ashe S; Johnston J; Li Y; Hellström I; Hellström KE
    J Exp Med; 1994 Feb; 179(2):523-32. PubMed ID: 7507508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cytotoxic T lymphocyte responses by cholera toxin-treated bone marrow-derived dendritic cells.
    Jang MH; Kweon MN; Hiroi T; Yamamoto M; Takahashi I; Kiyono H
    Vaccine; 2003 Apr; 21(15):1613-9. PubMed ID: 12639482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation.
    Talay O; Shen CH; Chen L; Chen J
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2741-6. PubMed ID: 19202065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
    Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
    J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis.
    Saudemont A; Quesnel B
    Blood; 2004 Oct; 104(7):2124-33. PubMed ID: 15191948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
    Blank C; Kuball J; Voelkl S; Wiendl H; Becker B; Walter B; Majdic O; Gajewski TF; Theobald M; Andreesen R; Mackensen A
    Int J Cancer; 2006 Jul; 119(2):317-27. PubMed ID: 16482562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
    Saudemont A; Jouy N; Hetuin D; Quesnel B
    Blood; 2005 Mar; 105(6):2428-35. PubMed ID: 15536145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.
    Kim HK; Guan H; Zu G; Li H; Wu L; Feng X; Elmets C; Fu Y; Xu H
    J Leukoc Biol; 2006 Apr; 79(4):686-95. PubMed ID: 16461745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
    Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
    Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.
    Fan Y; Jiang WZ; Wen JJ; Hao WL; Du JN; Liu X; Qian M
    Arch Virol; 2009; 154(11):1813-21. PubMed ID: 19838621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth.
    Yeh KY; Chen Z; Nasir A; Ohsuga Y; Takashima A; Lord EM; Gaspari AA
    J Invest Dermatol; 1997 Dec; 109(6):728-33. PubMed ID: 9406812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.